CDMO News
Simtra BioPharma Invests $14M to Expand ADC Manufacturing Capabilities
Simtra BioPharma Solutions, a contract development and manufacturing organisation (CDMO) specialising in sterile injectables, has announced a $14 million investment aimed at expanding its clinical-scale conjugation and purification services for Antibody-Drug Conjugates (ADCs). The investment is part of Simtra’s broader